(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3838.42 | 5380.11 | -28.66 | 3838.42 | 5380.11 | -28.66 | 20893.12 | 18406.49 | 13.51 |
| Other Income | 286.00 | 277.28 | 3.14 | 286.00 | 277.28 | 3.14 | 1820.75 | 1094.40 | 66.37 |
| PBIDT | 1594.33 | 2231.57 | -28.56 | 1594.33 | 2231.57 | -28.56 | 10331.96 | 7984.49 | 29.40 |
| Interest | 7.63 | 16.06 | -52.49 | 7.63 | 16.06 | -52.49 | 65.47 | 90.89 | -27.97 |
| PBDT | 1586.70 | 2215.51 | -28.38 | 1586.70 | 2215.51 | -28.38 | 10026.36 | 7893.60 | 27.02 |
| Depreciation | 223.10 | 226.12 | -1.34 | 223.10 | 226.12 | -1.34 | 995.65 | 779.37 | 27.75 |
| PBT | 1363.60 | 1989.39 | -31.46 | 1363.60 | 1989.39 | -31.46 | 9030.71 | 7114.23 | 26.94 |
| TAX | 343.50 | 505.98 | -32.11 | 343.50 | 505.98 | -32.11 | 2325.06 | 2052.36 | 13.29 |
| Deferred Tax | -3.55 | 5.29 | -167.11 | -3.55 | 5.29 | -167.11 | -87.99 | 232.08 | -137.91 |
| PAT | 1020.10 | 1483.41 | -31.23 | 1020.10 | 1483.41 | -31.23 | 6705.65 | 5061.87 | 32.47 |
| Equity | 1126.77 | 1123.22 | 0.32 | 1126.77 | 1123.22 | 0.32 | 1123.43 | 1118.15 | 0.47 |
| PBIDTM(%) | 41.54 | 41.48 | 0.14 | 41.54 | 41.48 | 0.14 | 49.45 | 43.38 | 14.00 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1942.95 |
| Dr. Reddys Labs. | 1183.00 |
| Cipla | 1415.10 |
| Lupin | 2405.80 |
| Zydus Lifesciences | 1129.75 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: